Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Relevant Treatment Approaches||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|KIT M552_K558del||gastrointestinal stromal tumor||predicted - resistant||KIT Inhibitor||Ponatinib||Case Reports/Case Series||Actionable||In a clinical study, a GIST patient harboring KIT M552_K558del, resistant to multiple tyrosine kinase inhibitors, demonstrated resistance to Iclusig (ponatinib) treatment as indicated by disease progression after 4 weeks of treatment (PMID: 25239608).||25239608|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|